Intuitive Surgical, Inc. (NASDAQ:ISRG) SVP Sells $19,591,902.12 in Stock

Intuitive Surgical, Inc. (NASDAQ:ISRGGet Free Report) SVP Henry L. Charlton sold 40,243 shares of the firm’s stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $486.84, for a total value of $19,591,902.12. Following the transaction, the senior vice president now owns 3,001 shares in the company, valued at $1,461,006.84. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG opened at $482.21 on Thursday. Intuitive Surgical, Inc. has a 52 week low of $254.85 and a 52 week high of $493.97. The stock’s fifty day moving average is $451.45 and its 200 day moving average is $412.69. The stock has a market capitalization of $171.04 billion, a P/E ratio of 87.04, a PEG ratio of 4.97 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRGGet Free Report) last issued its quarterly earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.54 by $0.24. Intuitive Surgical had a return on equity of 13.04% and a net margin of 27.65%. The company had revenue of $2.01 billion for the quarter, compared to analyst estimates of $1.97 billion. During the same quarter last year, the company posted $1.18 EPS. The company’s revenue for the quarter was up 14.5% compared to the same quarter last year. Equities research analysts forecast that Intuitive Surgical, Inc. will post 5.22 earnings per share for the current year.

Institutional Trading of Intuitive Surgical

Hedge funds have recently made changes to their positions in the company. Ridgewood Investments LLC acquired a new stake in shares of Intuitive Surgical in the 2nd quarter valued at about $26,000. Creekmur Asset Management LLC lifted its stake in Intuitive Surgical by 200.0% during the 1st quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 42 shares in the last quarter. LGT Financial Advisors LLC grew its stake in shares of Intuitive Surgical by 415.4% in the 2nd quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock worth $30,000 after acquiring an additional 54 shares in the last quarter. Delos Wealth Advisors LLC raised its holdings in shares of Intuitive Surgical by 380.0% in the first quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 57 shares during the last quarter. Finally, LRI Investments LLC purchased a new position in Intuitive Surgical during the first quarter worth about $30,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on the stock. JPMorgan Chase & Co. lifted their price target on shares of Intuitive Surgical from $475.00 to $495.00 and gave the company an “overweight” rating in a research report on Friday, July 19th. Barclays lifted their target price on shares of Intuitive Surgical from $430.00 to $490.00 and gave the stock an “overweight” rating in a report on Thursday, July 18th. Redburn Atlantic raised Intuitive Surgical from a “neutral” rating to a “buy” rating and raised their target price for the company from $380.00 to $510.00 in a report on Friday, August 2nd. Truist Financial upped their price target on Intuitive Surgical from $450.00 to $515.00 and gave the stock a “buy” rating in a report on Tuesday, July 16th. Finally, Stifel Nicolaus increased their price target on shares of Intuitive Surgical from $430.00 to $475.00 and gave the company a “buy” rating in a report on Friday, July 19th. Six research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and an average target price of $446.45.

Get Our Latest Stock Analysis on ISRG

Intuitive Surgical Company Profile

(Get Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Further Reading

Insider Buying and Selling by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.